SOL-GEL CANNABINOID FORMULATION AND ANTIVIRAL USE

The present invention relates to an antiviral cannabinoid-containing thermoresponsive sol-gel formulation and its use in the treatment or prevention of viruses such as Coronaviruses. In particular embodiments, the cannabinoid containing thermoresponsive sol-gel formulation is adapted for nasal deliv...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	DEVENTER, STEPHEN VAN
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to an antiviral cannabinoid-containing thermoresponsive sol-gel formulation and its use in the treatment or prevention of viruses such as Coronaviruses. In particular embodiments, the cannabinoid containing thermoresponsive sol-gel formulation is adapted for nasal delivery and comprises a micellar composition comprising a cannabinoid composition having at least 70% cannabidiol (CBD). La présente invention concerne une formulation sol-gel thermosensible contenant un cannabinoïde antiviral et son utilisation dans le traitement ou la prévention de virus tels que des Coronavirus. Dans des modes de réalisation particuliers, la formulation sol-gel thermosensible contenant des cannabinoïdes est adaptée pour une administration nasale et comprend une composition micellaire comprenant une composition cannabinoïde ayant au moins 70 % de cannabidiol (CBD).